IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”) recently released an announcement that Dr. Horst G Zerbe, its CEO will be holding a conference at 10 O’clock AM EST on July 23. This conference call is proposed in order to discuss important management change issues and also provide updates to the business representatives.
In addition to this conference call, Zerbe will also be supplying a webcast to accompany the conference call. Registration information and conference call details are available on the website, under investor relations at www.intelgenix.
IntelGenx is a delivery company that delivers pharmaceutical products that are orally administered and controlled. IntelGenx consists of a multi-faceted delivery system which provides drugs that are “control released” meaning they have a 0 order in the way that they are metabolized in the gastro-tract. These types of oral drug products are becoming popularly used throughout the world.
Such classifications of drugs that IntelGenx delivers in its product lines are used for a number of health ailments including: insomnia, migraines, erectile dysfunction, hypertension, depression, anxiety disorders, pulmonary fibrosis, cancer drugs, and even veterinarian medicines.